309 related articles for article (PubMed ID: 23487168)
1. A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists.
Michel MC; Foster C; Brunner HR; Liu L
Pharmacol Rev; 2013 Apr; 65(2):809-48. PubMed ID: 23487168
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers.
Kakuta H; Sudoh K; Sasamata M; Yamagishi S
Int J Clin Pharmacol Res; 2005; 25(1):41-6. PubMed ID: 15864875
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of angiotensin II receptor antagonists.
Timmermans PB
Can J Cardiol; 1999 Nov; 15 Suppl F():26F-8F. PubMed ID: 10579749
[TBL] [Abstract][Full Text] [Related]
4. Class- and molecule-specific differential effects of angiotensin II type 1 receptor blockers.
Imaizumi S; Miura S; Yahiro E; Uehara Y; Komuro I; Saku K
Curr Pharm Des; 2013; 19(17):3002-8. PubMed ID: 23176212
[TBL] [Abstract][Full Text] [Related]
5. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b.
Marshall TG; Lee RE; Marshall FE
Theor Biol Med Model; 2006 Jan; 3():1. PubMed ID: 16403216
[TBL] [Abstract][Full Text] [Related]
6. The place of ARBs in heart failure therapy: is aldosterone suppression the key?
Markan U; Pasupuleti S; Pollard CM; Perez A; Aukszi B; Lymperopoulos A
Ther Adv Cardiovasc Dis; 2019; 13():1753944719868134. PubMed ID: 31401939
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of angiotensin receptor blocker monotherapy in patients with hypertension in the Netherlands: a comparative analysis using clinical trial and drug utilization data.
Boersma C; Voors AA; Visser ST; de Jong-van den Berg LT; Postma MJ
Am J Cardiovasc Drugs; 2010; 10(1):49-54. PubMed ID: 20104934
[TBL] [Abstract][Full Text] [Related]
8. Renal protection with angiotensin receptor blockers: where do we stand.
Schmieder RE; Ruilope LM; Barnett AH
J Nephrol; 2011; 24(5):569-80. PubMed ID: 21404225
[TBL] [Abstract][Full Text] [Related]
9. Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system.
Kurtz TW; Pravenec M
Am J Hypertens; 2008 Aug; 21(8):852-9. PubMed ID: 18535538
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
11. Comparative antihypertensive effects of angiotensin II receptor antagonists.
Burnier M; Brunner HR
J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S278-82. PubMed ID: 10201883
[TBL] [Abstract][Full Text] [Related]
12. AT(1)-receptor blockers: differences that matter.
Gradman AH
J Hum Hypertens; 2002 Aug; 16 Suppl 3():S9-S16. PubMed ID: 12140723
[TBL] [Abstract][Full Text] [Related]
13. Have angiotensin receptor blockers lived up to expectations?
Fitchett D
Can J Cardiol; 2005 May; 21(7):569-75. PubMed ID: 15940354
[TBL] [Abstract][Full Text] [Related]
14. Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism.
Van Liefde I; Vauquelin G
Mol Cell Endocrinol; 2009 Apr; 302(2):237-43. PubMed ID: 18620019
[TBL] [Abstract][Full Text] [Related]
15. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
16. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
Izuhara Y; Sada T; Yanagisawa H; Koike H; Ohtomo S; Dan T; Ito S; Nangaku M; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
[TBL] [Abstract][Full Text] [Related]
17. Candesartan: widening indications for this angiotensin II receptor blocker?
Mendis B; Page SR
Expert Opin Pharmacother; 2009 Aug; 10(12):1995-2007. PubMed ID: 19563275
[TBL] [Abstract][Full Text] [Related]
18. The comparative pharmacology of angiotensin II receptor antagonists.
Burnier M; Maillard M
Blood Press Suppl; 2001; 1():6-11. PubMed ID: 11333013
[TBL] [Abstract][Full Text] [Related]
19. Drug Interactions with Angiotensin Receptor Blockers: Role of Human Cytochromes P450.
Yang R; Luo Z; Liu Y; Sun M; Zheng L; Chen Y; Li Y; Wang H; Chen L; Wu M; Zhao H
Curr Drug Metab; 2016; 17(7):681-91. PubMed ID: 27216792
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
